Financhill
Back

Verve Therapeutics Stock Predictions

Verve Therapeutics Stock Forecast

  • Is Verve Therapeutics Stock Undervalued?
    The current Verve Therapeutics [VERV] share price is $4.85. The Score for VERV is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • VERV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Verve Therapeutics Stock Go Up Next Year?

Data Unavailable

Verve Therapeutics Stock Rating

Data Unavailable

Verve Therapeutics Stock Price History

Is VERV stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vervetx.com

52-Week Data

52-Week High:
19.34
52-Week Low:
4.31

Prediction Charts

Market Cap:
410.62M
Price in USD:
4.85
Volume:
1.13M
Beta:
1.79

Technical Analysis

SMA50:
5.36
SMA100:
5.68
SMA200:
7.32
52-Wk Change:
-59.72%

Stock Predictions

  • Is Verve Therapeutics stock public?
    Yes, Verve Therapeutics is a publicly traded company.
  • What is the Verve Therapeutics stock quote today?
    The Verve Therapeutics stock price is 4.85 USD today.
  • How to buy Verve Therapeutics stock online?
    You can buy Verve Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 6.19 6.38 6.77 6.14
Nov-6 6.45 6.42 6.81 6.28
Nov-7 6.41 6.36 6.64 6.02
Nov-8 6.36 6.31 6.39 6.15
Nov-11 6.43 6.42 6.75 6.26
Nov-12 6.33 6.43 6.50 6.21
Nov-13 6.51 5.79 6.68 5.78
Nov-14 5.75 5.38 5.83 5.37
Nov-15 5.44 4.79 5.44 4.78
Nov-18 4.85 4.50 4.92 4.48
Nov-19 4.49 4.84 4.93 4.49
Nov-20 4.84 4.55 4.84 4.48
Nov-21 4.55 4.60 4.69 4.44
Nov-22 4.50 4.85 4.87 4.50

Verve Therapeutics Earnings

Data Unavailable

Verve Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and a decrease next year of $0.48 per share.

* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.